The binding mode of the bispecific anti-HER2xHER3 antibody MCLA-128 is responsible for its potent inhibition of HRG-driven tumorigenesis
- Resource Type
- Journal
- Source
CANCER RESEARCH ; JUL 2017, 77 2p. Supplement: 13- Subject
- Language
- English
- ISSN
- 15387445